The combined results of our study not only provide a comprehensive characterization of the immune responses after COVID-19 but also demonstrate that the severity of the initial disease predominantly affects cellular and humoral immunity against the Spike (S) protein even months after recovery from SARS-CoV-2 infection. The gene discussed is CHMP5; the disease is COVID-19.